| 2005 |
MDC1 BRCT repeat domain directly binds the phosphorylated C-terminal tail of histone H2AX (γH2AX) in a phosphorylation-dependent manner; X-ray crystal structure of the MDC1 BRCT domain in complex with the γH2AX phosphopeptide revealed that Arg1932 and Arg1933 recognize the C-terminal carboxylate and penultimate Glu of H2AX, and this interaction is critically dependent on the free C-terminal carboxylate of Tyr in the γH2AX tail. MDC1-γH2AX complex formation regulates H2AX phosphorylation and is required for normal radioresistance and efficient accumulation of DNA-damage-response proteins on damaged chromatin. |
X-ray crystallography, biochemical binding assays, cell biology (focus formation, RNAi knockdown), mutagenesis |
Cell |
High |
16049003 16377563
|
| 2005 |
The tandem BRCT repeats of MDC1 directly bind the phosphorylated γH2AX tail (pSer-Gln-Glu-Tyr-COO−) in a manner critically dependent on the free C-terminal carboxylate of the C-terminal Tyr residue; X-ray crystal structure at 1.45 Å resolution of the MDC1 BRCT repeats was determined, and Arg1932/Arg1933 were identified as key recognition residues for both the phosphate and the C-terminal carboxylate. |
X-ray crystallography (1.45 Å), in vitro binding assays with phosphopeptides, comparison with BRCA1 BRCT structure |
The Journal of biological chemistry |
High |
16049003
|
| 2003 |
MDC1 forms complexes with phosphorylated H2AX in a phosphorylation-dependent manner; siRNA depletion of MDC1 impairs formation of 53BP1, BRCA1, and MRN foci, partially by reducing efficient H2AX phosphorylation; MDC1 is required for proper intra-S phase and G2/M checkpoint activation and Chk1 regulation after ionizing radiation. |
siRNA knockdown, immunofluorescence (focus formation), phosphopeptide binding assay, cell cycle checkpoint assays |
Nature |
High |
12607005
|
| 2003 |
MDC1 (KIAA0170) contains FHA and BRCT domains; its FHA domain mediates binding to phosphorylated Thr68 of activated CHK2; MDC1 is phosphorylated in an ATM/CHK2-dependent manner after DNA damage; MDC1 suppression causes defective S-phase checkpoint and reduced apoptosis restored only by wild-type MDC1 but not FHA-deleted MDC1; MDC1 is upstream of p53 stabilization in the ATM-CHK2 pathway. |
Co-immunoprecipitation, phosphopeptide binding, siRNA knockdown, rescue experiments with deletion mutants, cell cycle and apoptosis assays |
Nature |
High |
12607004
|
| 2003 |
MDC1 (KIAA0170/NFBD1) binds the MRE11 complex (MRE11-RAD50-NBS1) as an interaction partner; MDC1 is hyperphosphorylated in an ATM-dependent manner after ionizing radiation; siRNA depletion of MDC1 causes a radio-resistant DNA synthesis (RDS) phenotype and prevents ionizing radiation-induced MRE11 complex focus formation; overexpression of the MDC1 FHA domain acts dominantly to interfere with MDC1 and MRE11 focus formation and induces RDS; MDC1-mediated MRN focus formation is crucial for efficient intra-S-phase checkpoint activation. |
Protein interaction (co-immunoprecipitation), siRNA knockdown, dominant-negative overexpression, RDS assay, focus formation assays |
Nature |
High |
12607003
|
| 2006 |
MDC1 directly mediates the interaction between γH2AX and ATM through its BRCT domain (γH2AX binding) and FHA domain (ATM binding), forming a positive feedback loop in which MDC1 accumulates activated ATM at DSB sites to facilitate further ATM-dependent H2AX phosphorylation and signal amplification. MDC1-knockout mice recapitulate H2AX-/- phenotypes including growth retardation, male infertility, immune defects, chromosome instability, and radiation sensitivity. |
Gene knockout (MDC1-/- mice), domain-function analysis (BRCT and FHA binding assays), epistasis with H2AX-/- mice, ATM co-immunoprecipitation |
Molecular cell |
High |
16427009
|
| 2004 |
MDC1 functions as an H2AX-dependent interaction platform enabling a switch from transient, MDC1-independent recruitment of NBS1 to DSBs to sustained, MDC1-dependent retention of NBS1 in DSB-flanking chromatin. MDC1 becomes partially immobilized (chromatin-bound) after DSB generation in an H2AX-dependent manner; depletion of H2AX prevents MDC1 relocalization and uncouples NBS1 from DSB-flanking chromatin. |
Live-cell imaging (FRAP), siRNA knockdown, chromatin fractionation, focus formation assays |
The EMBO journal |
High |
15201865
|
| 2008 |
MDC1 is phosphorylated by casein kinase 2 (CK2) on a cluster of conserved repeat motifs (SDT repeats); this CK2-dependent phosphorylation promotes direct, phosphorylation-dependent interaction with the FHA and twin BRCT domains of NBS1; mutation of the CK2-targeted motifs in MDC1 or CK2 depletion disrupts MDC1-NBS1 interaction and abrogates accumulation of the MRN complex at DSB sites in vivo. |
In vitro kinase assay (CK2 phosphorylation), direct binding assay, siRNA knockdown of CK2, mutagenesis of MDC1 SDT motifs, focus formation assays, Co-IP |
EMBO reports |
High |
18411307 18411308 18583988
|
| 2008 |
MDC1 contains multiple conserved acidic sequence motifs (SDT repeats) that are constitutively phosphorylated by CK2 in vitro and in vivo; these phosphorylated SDT motifs directly interact with the N-terminal FHA domain of NBS1 in a phosphorylation-dependent manner; mutation of these motifs or CK2 depletion disrupts MDC1-NBS1 interaction and abrogates MRN complex focus formation at DSBs. |
In vitro kinase assay (CK2), direct binding (GST pulldown with phosphopeptides), siRNA knockdown of CK2, mutagenesis of MDC1 SDT motifs, focus formation assays |
The Journal of cell biology |
High |
18411308
|
| 2008 |
NBS1 interacts with MDC1 N-terminal SDT repeats constitutively; this interaction is mediated by phosphorylated SDT repeats binding to the NBS1 FHA domain; phosphorylation of SDT repeats by CK2 is sufficient to trigger MDC1-NBS1 interaction in vitro; MDC1 associates with CK2 activity in cells; disruption of the SDT phosphoacceptor sites prevents NBS1 retention at DSBs. |
In vitro binding assay, in vitro kinase assay, CK2 inhibition, mutagenesis of MDC1 SDT repeats, focus formation, Co-IP |
The Journal of cell biology |
High |
18411307
|
| 2008 |
MDC1 directly binds to NBS1 through a region (residues 200-420) containing multiple CK2 phosphorylation sites; this interaction requires both the FHA and tandem BRCT domains of NBS1; disruption of the MDC1-NBS1 interaction results in failure of NBS1 accumulation at DSBs and impairment of intra-S checkpoint activation. |
Direct binding assay, domain mapping (deletion mutants), siRNA, focus formation, S-phase checkpoint assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
18678890
|
| 2005 |
MDC1 controls the dynamic assembly and sustained retention of 53BP1 at DSB sites; siRNA depletion of MDC1 drastically impairs 53BP1 redistribution to DSBs and causes premature dissociation of 53BP1. Real-time microscopy showed 53BP1 assembly at DSBs significantly lags behind MDC1, establishing MDC1 as an upstream determinant of 53BP1 interaction with DSBs. |
Real-time live-cell microscopy, siRNA knockdown, quantitative single-cell imaging, FRAP |
The Journal of cell biology |
High |
16009723
|
| 2008 |
53BP1 directly interacts with MDC1 through the tandem BRCT domain of MDC1 and residues 1288-1409 of 53BP1; this interaction is reduced following DSB induction (competition with γH2AX for BRCT binding) and is enhanced during mitosis in a phospho-dependent manner; the MDC1-binding region of 53BP1 is required for 53BP1 focus formation at DSB sites. |
Direct binding assay (in vitro), co-immunoprecipitation, domain mapping with deletion mutants, focus formation assays, cell cycle analysis |
The Journal of biological chemistry |
High |
18986980
|
| 2007 |
MDC1 functions primarily in homologous recombination/sister chromatid recombination in a manner strictly dependent on its ability to interact with γH2AX; this function does not require 53BP1 or BRCA1 recruitment to γH2AX chromatin. In contrast, 53BP1 functions in XRCC4-dependent NHEJ independently of H2AX, indicating distinct specialization of these two mediators. |
Genetic epistasis (double mutant analysis), DSB repair assays (HR vs NHEJ), siRNA knockdown, plasmid-based repair assays |
Molecular cell |
High |
18158901
|
| 2004 |
MDC1 directly interacts with the Ku/DNA-PKcs complex via its repeat region; MDC1 depletion results in defective phospho-DNA-PKcs foci formation and DNA-PKcs autophosphorylation; DNA-PK-dependent DNA damage repair is defective in MDC1-depleted cells, indicating MDC1 regulates DNA-PKcs autophosphorylation following DNA damage. |
Co-immunoprecipitation, siRNA knockdown, focus formation assay, DNA-PKcs autophosphorylation assay, NHEJ repair assay |
The Journal of biological chemistry |
Medium |
15377652
|
| 2005 |
MDC1 forms a complex with Rad51 through a direct interaction with the MDC1 FHA domain; MDC1 depletion results in impaired Rad51 IRIF formation, reduced nuclear and chromatin-bound Rad51, increased Rad51 protein degradation, and impaired homology-mediated DSB repair; MDC1 functions in Rad51-mediated homologous recombination by retaining Rad51 in chromatin. |
Co-immunoprecipitation, siRNA knockdown, direct binding assay, Rad51 focus formation, HR repair assay, chromatin fractionation |
Nature structural & molecular biology |
Medium |
16186822
|
| 2009 |
MDC1 is required for RNF8 recruitment to sites of UV-induced DNA damage, establishing a novel function for MDC1 as a scaffold for RNF8 in the nucleotide excision repair (NER)-dependent DNA damage response, leading to H2A ubiquitination at UV damage sites, 53BP1 and BRCA1 recruitment. |
Co-immunoprecipitation (MDC1-RNF8 interaction), siRNA knockdown, immunofluorescence, NER assay, UV sensitivity assay |
The Journal of cell biology |
Medium |
19797077
|
| 2011 |
MDC1 defines the chromosome-wide domain of γH2AX spreading on sex chromosomes during male meiosis, initiates meiotic sex chromosome inactivation (MSCI), and leads to XY body formation. MDC1-dependent chromosome-wide spreading of DDR factors constitutes a second step after MDC1-independent recognition of the unsynapsed axis by ATR, TOPBP1, and γH2AX. |
Genetic analysis (MDC1-knockout mice), immunofluorescence, ChIP, epistasis with H2AX and ATR |
Genes & development |
High |
21536735
|
| 2012 |
MDC1 is sumoylated at Lys1840 following DNA damage; this sumoylation is recognized by the SUMO-targeted E3 ubiquitin ligase RNF4, which ubiquitinates MDC1, promoting its degradation and removal from DSB sites; K1840R mutation impairs CtIP, RPA, and Rad51 accumulation at DSBs and causes HR defect that can be rescued by 53BP1 downregulation. |
In vivo sumoylation assay, mutagenesis (K1840R), siRNA, immunofluorescence (focus formation), HR assay, Co-IP (RNF4-MDC1 interaction) |
The EMBO journal |
High |
22635276
|
| 2013 |
JMJD1C demethylase demethylates MDC1 at Lys45, promoting MDC1-RNF8 interaction and RNF8-dependent MDC1 ubiquitylation, which is required for recruitment of the RAP80-BRCA1 complex to DSBs. JMJD1C is stabilized by interaction with RNF8 and is recruited to DSBs, specifically regulating the RAP80-BRCA1 branch (not 53BP1 branch) of the DDR. |
Co-immunoprecipitation, in vitro demethylation assay, siRNA, immunofluorescence, mass spectrometry identification of methylation site |
Nature structural & molecular biology |
High |
24240613
|
| 2018 |
EHMT1 and EHMT2 (lysine methyltransferases) methylate MDC1 at Lys45; EHMT1 interacts with MDC1 in a manner facilitated by DNA damage-initiated ATM signaling; EHMT2 dominantly modulates MDC1 Lys45 methylation; this methylation promotes the interaction between MDC1 and ATM, expanding activated ATM on damaged chromatin and at dysfunctional telomeres, and is required for accumulation of 53BP1 and RAP80 at DSBs. |
Co-immunoprecipitation, in vitro methyltransferase assay, siRNA knockdown, mass spectrometry, immunofluorescence |
Scientific reports |
Medium |
30022091
|
| 2012 |
The MDC1 FHA domain mediates phosphorylation-dependent dimerization of MDC1 in response to DNA damage; crystal structures of the FHA domain reveal a face-to-face dimer with pseudo-dyad symmetry; the FHA domain binds in trans to phospho-Thr4 (pT4) at the N-terminus of MDC1 from the other subunit; T4 is phosphorylated primarily by ATM upon DNA damage; MDC1 mutants with impaired dimerization form fewer foci at DNA-damage sites. |
X-ray crystallography, in vitro binding assay (pT4 peptide), phospho-site mapping (ATM), mutagenesis, focus formation assays, artificial dimerization rescue |
Nucleic acids research |
High |
22234877 22234878
|
| 2012 |
The MDC1 FHA domain undergoes ATM-dependent dimerization by binding a phosphorylation site near the N-terminus of MDC1 itself; X-ray structures reveal a 'head-to-tail' dimerization mechanism related to pre-activated Chk2; this dimerization both positively and negatively influences MDC1 FHA domain-mediated interactions in human cells. |
X-ray crystallography, phosphosite identification, in vitro binding assays, cellular interaction studies |
Nucleic acids research |
High |
22234878
|
| 2009 |
Aprataxin binds to MDC1/NFBD1 through a phosphorylation-dependent interaction mediated by the aprataxin FHA domain and multiple CK2 di-phosphorylated S-D-T-D motifs in MDC1; X-ray structural and mutagenic analysis of the aprataxin FHA domain revealed an unusual FHA binding mechanism mediated by a cluster of basic residues; mutation of aprataxin FHA Arg29 prevented its interaction with MDC1 and recruitment to sites of DNA damage. |
Co-immunoprecipitation, X-ray crystallography (FHA-pSDpTD peptide complex), mutagenesis (Arg29 mutation), focus formation assay |
Nucleic acids research |
High |
20008512
|
| 2011 |
MDC1 interacts with TOPBP1 via the 5th BRCT domain (BRCT5) of TopBP1 and the SDT repeats of MDC1; TopBP1 accumulation at stalled replication forks is promoted by the H2AX/MDC1 signaling cascade; MDC1 is important for ATR-dependent Chk1 activation in response to replication stress. |
Co-immunoprecipitation, domain mapping (deletion mutants), siRNA, focus formation at stalled forks, Chk1 phosphorylation assay |
The Journal of cell biology |
Medium |
21482717
|
| 2013 |
X-ray crystal structures of TopBP1 tandem BRCT4/5 domains free and in complex with a MDC1 consensus pSDpT phosphopeptide revealed that TopBP1 BRCT4/5 adopts a variant BRCT-BRCT packing interface and recognizes the MDC1 phosphopeptide in a manner distinct from other tandem BRCT-peptide structures; mutations in the phosphate-binding pocket of BRCT5 reduced binding affinity and impaired TopBP1 recruitment to γH2AX foci in cells. |
X-ray crystallography (TopBP1 BRCT4/5 free and bound to MDC1 pSDpT peptide), fluorescence polarization binding assay, mutagenesis, focus formation assay |
Structure |
High |
23891287
|
| 2019 |
MDC1 interacts with TOPBP1 via a conserved CK2-phosphorylated protein-interaction surface; disruption of MDC1-TOPBP1 binding causes specific loss of TOPBP1 recruitment to DSBs in mitotic (not interphase) cells, increased micronuclei, chromosomal instability, and mitotic radiosensitivity; TOPBP1 forms filamentous structures that bridge MDC1 foci in mitosis, tethering DSBs until repair is reactivated in G1. |
CRISPR-Cas9 mutagenesis, Co-immunoprecipitation, super-resolution microscopy, immunofluorescence, chromosomal instability assay, clonogenic survival assay |
Molecular cell |
High |
30898438
|
| 2010 |
MDC1 directly binds the APC/C (anaphase-promoting complex/cyclosome) E3 ubiquitin ligase through its tandem BRCT domain and the phosphorylated C-terminus of the Cdc27 (APC3) subunit; this interaction is enhanced after DNA damage; phosphopeptides corresponding to γH2AX and Cdc27 C-termini compete for binding to MDC1; MDC1 depletion by siRNA causes metaphase arrest, reduced APC/C activity, and failure of Cdc20 to bind APC/C, establishing MDC1 as a regulator of metaphase-to-anaphase transition. |
Co-immunoprecipitation, direct binding assay, phosphopeptide competition, siRNA knockdown, APC/C ubiquitin ligase activity assay, cell cycle analysis |
The Journal of biological chemistry |
Medium |
17827148 19826003
|
| 2014 |
MDC1 localizes to mitotic kinetochores following spindle assembly checkpoint (SAC) activation in an ATM-dependent manner; ATM phosphorylates H2AX at mitotic kinetochores, and this phosphorylation is required for MDC1 kinetochore localization; ATM and MDC1 are needed for kinetochore localization of mitotic checkpoint complex components Mad2 and Cdc20, and for maintenance of MCC integrity. |
Immunofluorescence (MDC1/Mad2/Cdc20 at kinetochores), siRNA knockdown of ATM and MDC1, H2AX phosphorylation analysis, SAC activation assay, Co-IP (MDC1-MCC interaction) |
The Journal of biological chemistry |
Medium |
24509855
|
| 2010 |
MDC1 is cleaved by caspase-3 during apoptosis, separating its BRCT and FHA domains; this cleavage constitutes a mechanism for inactivating DNA repair by preventing MDC1 from binding γH2AX and amplifying the DDR in apoptotic cells; MDC1 downregulation increases the apoptotic response to TRAIL. |
In vitro caspase-3 cleavage assay, immunoblotting, siRNA knockdown, TRAIL-induced apoptosis assay, γH2AX focus formation |
Cancer research |
Medium |
21148072
|
| 2006 |
MDC1 knockdown reduces accumulation of phosphorylated ATM, 53BP1, and Nbs1 at dysfunctional telomere foci (TIFs); the rate of NHEJ of dysfunctional telomeres is significantly decreased when MDC1 or its chromatin recruitment is inhibited; MDC1 promotes a step in NHEJ after 3' telomeric overhang removal, independently of ATM-dependent cell cycle arrest. |
siRNA knockdown, immunofluorescence (TIF assay), telomere fusion assay (NHEJ quantification), epistasis with Nbs1/53BP1 knockdowns |
Genes & development |
Medium |
17158742
|
| 2008 |
MDC1 is ubiquitylated and directed for proteasome-dependent degradation, which drives disassembly of MDC1 foci; ubiquitylated MDC1 associates with chromatin before and after IR; blocking proteasome activity causes persistent MDC1 foci and is associated with abrogated BRCA1 focus recruitment in an RNF8-independent manner. |
Ubiquitylation assay, proteasome inhibition, chromatin immunoprecipitation, immunofluorescence, immunoblotting |
The Journal of biological chemistry |
Medium |
18757370
|
| 2011 |
MDC1 is ubiquitylated on K1977 of its tandem BRCT domain in a UBC13-dependent manner; MDC1 directly binds RAP80 through the MDC1 tandem BRCT domain and the ubiquitin-interacting motifs of RAP80; this interaction depends on K63-linked poly-ubiquitin chain formation by UBC13. |
Co-immunoprecipitation, direct binding assay, ubiquitylation site mapping (K1977), UBC13 inhibition/depletion, domain mapping |
DNA repair |
Medium |
21622030
|
| 2011 |
ATM phosphorylates MDC1 at Thr98 following DNA damage, which promotes MDC1 oligomerization; oligomerization is important for accumulation of MDC1 complex at DSB sites; T98A mutation abolishes oligomerization and results in defective DNA damage checkpoint activation and increased IR sensitivity. |
In vitro kinase assay (ATM phosphorylation of T98), mutagenesis (T98A), Co-immunoprecipitation (oligomerization), focus formation assay, checkpoint activation assay, clonogenic survival |
The Journal of biological chemistry |
Medium |
21705321
|
| 2012 |
MDC1 directly interacts with RAG1 via two binding interfaces: (1) the MDC1 tandem BRCT domain binds the RAG1 C-terminal H2AX-like motif (R1Ct), likely requiring phosphorylation of R1Ct; (2) the MDC1 PST repeats bind the N-terminal non-core region of RAG1 (R1Nt) constitutively. |
Co-immunoprecipitation, direct binding assay (GST pulldown), domain mapping with deletion mutants |
The Journal of biological chemistry |
Medium |
22942284
|
| 2019 |
The MDC1 PST-repeat region directly interacts with chromatin via the nucleosome acidic patch, mediating H2AX-independent association of MDC1 with chromatin; this region is dispensable when the canonical γH2AX-MDC1 pathway is operative but becomes critical for 53BP1 recruitment and cell survival following DSB induction when H2AX is absent. |
CRISPR-Cas9 engineered cell lines (PST deletion, H2AX knockout), chromatin binding assay, nucleosome pulldown, focus formation assay, clonogenic survival |
Nature communications |
High |
31729360
|
| 2010 |
MOF-mediated acetylation of histone H4 Lys16 and an intact H2A.X acidic pocket are essential for recruitment of MDC1 to DNA damage foci; loss of MOF in conditional knockout cells abolished MDC1 recruitment (and downstream 53BP1, BRCA1 recruitment) despite normal early ATM signaling. |
Conditional knockout mouse model, derived MEFs, immunofluorescence (focus formation), charge-neutralizing H2AX mutant, epistasis analysis |
Molecular and cellular biology |
Medium |
20837706
|
| 2017 |
Ataxin-3 (a deubiquitylase) counteracts RNF4-mediated ubiquitylation of MDC1, stabilizing MDC1 at DSBs; loss of ataxin-3 decreases MDC1 chromatin dwell time (reversed by co-depletion of RNF4); ataxin-3 is recruited to DSBs in a SUMOylation-dependent fashion and directly interacts with SUMO in vitro, defining a SUMO-dependent DUB mechanism toward MDC1; ataxin-3 loss reduces RNF8 and RNF168 recruitment and downstream 53BP1/BRCA1 focus formation. |
siRNA knockdown, Co-IP, in vitro SUMO binding assay, FRAP (chromatin dwell time), double knockdown epistasis, NHEJ/HR repair assays |
The EMBO journal |
High |
28275011
|
| 2017 |
ASF1a (histone chaperone) interacts with MDC1 and is recruited to DSBs; ASF1a facilitates the interaction of phospho-ATM with MDC1 and the ATM-dependent phosphorylation of MDC1, which is required for RNF8/RNF168 recruitment, histone ubiquitination, 53BP1 recruitment, and NHEJ; this role is specific to ASF1a (not ASF1b) and does not require its histone chaperone activity. |
Co-immunoprecipitation, siRNA knockdown, phosphorylation assay, ubiquitination assay, NHEJ repair assay, focus formation assay, clonogenic survival |
Molecular cell |
Medium |
28943310
|
| 2007 |
MDC1 functions upstream of 53BP1 in the DDR pathway; MDC1 regulates 53BP1 focus formation and phosphorylation in response to DNA damage; loss of both MDC1 and 53BP1 does not significantly increase defects in DDR or tumor incidence compared with MDC1 loss alone, placing MDC1 upstream of 53BP1 in the ATM cascade. |
Double-knockout mouse model (MDC1-/-/53BP1-/-), siRNA, focus formation assay, tumor incidence analysis, DDR signaling assays |
The Journal of cell biology |
High |
18504301
|
| 2010 |
MDC1 is required for BRCT domain interaction with the APC/C Cdc27 subunit, regulating metaphase-to-anaphase transition; MDC1 depletion causes metaphase arrest independent of BubR1-dependent signaling and ATM/ATR activation, characterized by reduced Cdc20 levels and failure of Cdc20 to bind APC/C. |
siRNA knockdown, Co-IP (MDC1-APC/C), APC/C ubiquitin ligase activity assay, cell cycle analysis (FACS), immunofluorescence |
The Journal of biological chemistry |
Medium |
19826003
|
| 2015 |
MDC1 functions as a co-activator of androgen receptor (AR): MDC1 facilitates the association between AR and histone acetyltransferase GCN5, increasing histone H3 acetylation on cis-regulatory elements of AR target genes including p21 and Vinculin; MDC1 knockdown promotes PCa cell growth and migration and decreases expression of a subset of AR-induced target genes. |
Co-immunoprecipitation (MDC1-AR-GCN5 complex), ChIP (H3 acetylation at AR target gene promoters), siRNA knockdown, gene expression analysis |
Nucleic acids research |
Medium |
25934801
|
| 2007 |
NFBD1/MDC1 associates with p53 directly; MDC1 BRCT domain binds the N-terminal region of p53 and inhibits p53 Ser15 phosphorylation and p53 transcriptional activity; MDC1 knockdown increases adriamycin sensitivity in p53 wild-type but not p53-deficient cells. |
Co-immunoprecipitation, luciferase reporter assay (p53 transcription), siRNA knockdown, p53 phosphorylation assay, apoptosis assay |
The Journal of biological chemistry |
Medium |
17535811
|
| 2013 |
p53 and MDC1 directly interact in vitro; the interaction is mediated by the MDC1 tandem BRCT domain and the C-terminal domain of p53; acetylation of p53 Lys382 and phosphorylation of p53 Ser392 enhance the p53-MDC1 interaction; the p53-MDC1 interaction is augmented upon DNA damage induction in human cells. |
In vitro direct binding assay (recombinant proteins), co-immunoprecipitation (from cells), modified peptide binding assays |
PloS one |
Medium |
24194938
|
| 2002 |
NFBD1 (MDC1) is a chromatin-associated protein whose phosphorylation in response to ionizing radiation is ATM-dependent; it forms nuclear foci within 1 minute after IR that colocalize with γH2AX, 53BP1, and MRE11/RAD50 foci; it is modified in G2/M phase or after DNA damage. |
Immunofluorescence, chromatin fractionation, ATM-dependent phosphorylation assay (with ATM inhibitor/ATM-deficient cells), immunoblotting |
The Journal of biological chemistry |
Medium |
12499369
|
| 2009 |
MDC1 is essential for γH2AX formation at high densities near DSBs; MDC1 retains activated ATM in chromatin near DSBs to promote continued local phosphorylation of H2AX, fueling a γH2AX self-reinforcing mechanism; MDC1 is not required for γH2AX formation over distal sequences (which requires ATM but not MDC1). |
Genetic analysis (MDC1-knockout cells), ChIP (γH2AX density mapping), quantitative immunofluorescence, epistasis with ATM and DNA-PKcs |
Molecular cell |
High |
19450528
|
| 2012 |
The HTLV-1 viral oncoprotein Tax sequesters MDC1 to chromatin sites distinct from normal IRIF through the C-terminal half of Tax, which is critical for MDC1 binding; Tax expression induces H2AX phosphorylation and monoubiquitylation in an MDC1-dependent manner (ablated by siRNA suppression of MDC1); Tax-induced pseudo-DDR competes with normal cellular DDR, repressing Nbs1 IRIF formation. |
Co-immunoprecipitation, confocal microscopy, siRNA (MDC1), domain mapping (Tax N- and C-terminal mutants), H2AX ubiquitylation assay |
The Journal of biological chemistry |
Medium |
20729195
|
| 2023 |
In oocyte meiosis I, DSB-induced p-MDC1 and p-TOPBP1 are recruited from spindle poles to chromosomes in a CIP2A-dependent manner; this pole-to-chromosome relocation of the CIP2A-MDC1-TOPBP1 complex requires intact microtubules, kinetochore/centromere components (CENP-A, HEC1), and is regulated by PLK1 (not ATM); disruption of microtubules or CIP2A depletion impairs DSB repair during meiosis I. |
Immunofluorescence (live oocyte imaging), microtubule depolymerization, siRNA (CIP2A, CENP-A, HEC1), Co-immunoprecipitation (CIP2A-MDC1-TOPBP1), inhibitors (PLK1, ATM), DSB repair assay |
Nucleic acids research |
Medium |
36999590
|
| 2010 |
Comparison of crystal structures of BRCA1 and MDC1 BRCT domains bound to tetrapeptide substrates revealed that MDC1 has a much stronger preference for a free C-terminal carboxylate at the +3 position compared to BRCA1; a mutation in MDC1 inducing a more BRCA1-like conformation relaxes binding specificity to allow binding of phosphopeptides lacking a free C-terminus. |
X-ray crystallography (BRCA1 and MDC1 BRCT-peptide complexes), fluorescence polarization binding assay, mutagenesis |
Structure |
High |
20159462
|